InsiderDB
Sign inStart free trial

Sen. Mark R. Warner sold Halozyme Therapeutics (HALO)

Sen. Mark R. Warner (D-VA) · $500K–$1M · traded Nov 6, 2017

Transaction
Sold (full)
Amount
$500K–$1M
Owner
The member
Traded
Nov 6, 2017
Disclosed
Dec 8, 2017
Days to disclose
32
Asset type
Stock
As filed
Halozyme Therapeutics, Inc.
Industry
Biotechnology · Healthcare
Official filing ↗All of Warner's tradesAll Congress trades in HALO

Recent Congress trades in HALO

Company context for HALO

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. HALOFinancial report·SEC EDGAR

    HALO: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 5, 2026, 4:13 PM ESTEvent / period: Sep 30, 2026Original source ↗
  2. HALOCompany announcement·SEC EDGAR

    HALO: Financial results

    Filed 8-K for an event or period dated 2026-11-05. Financial results.

    Public: Nov 5, 2026, 4:08 PM ESTEvent / period: Nov 5, 2026Original source ↗
  3. HALOLobbying report·Lobbying disclosures

    HALO: third_quarter 2026 lobbying report

    Issues related to biopharmaceutical research, development, and manufacturing. Issues related to coverage and reimbursement.

    Public: Oct 18, 2026, 2:19 PM EDTOriginal source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.